Msefsl

CLOSE X

Risk Disclosures on Derivatives

>9 out of 10 individual traders in equity Futures and Options Segment, incurred net losses.
>On an average, loss makers registered net trading loss close to ₹ 50,000.
>Over and above the net trading losses incurred, loss makers expended an additional 28% of net trading losses as transaction costs.
>Those making net trading profits, incurred between 15% to 50% of such profits as transaction cost.

Source:

1. SEBI study dated January 25, 2023 on “Analysis of Profit and Loss of Individual Traders dealing in equity Futures and Options (F&O) Segment”, wherein Aggregate Level findings are based on annual Profit/Loss incurred by individual traders in equity F&O during FY 2021-22.

GENPHARMASEC LTD.

NSE : NABSE : 531592ISIN CODE : INE861N01036Industry : Dyes & PigmentsHouse : Private

BSE2.060 (0 %)

PREV CLOSE ( ) 2.06

OPEN PRICE ( ) 2.04

BID PRICE (QTY) 0.00 (0)

OFFER PRICE (QTY) 0.00 (0)

VOLUME 295918

TODAY'S LOW / HIGH ( )2.04 2.08

52 WK LOW / HIGH ( ) 1.894.32

NSE

This Company is not listed in NSE

Select year

(Rs.in Million)

Particulars

Mar 2024

Mar 2023

Profit Before Tax

2.51

2.82

Adjustment

3.85

1.64

Changes In working Capital

-35.41

-37.69

Cash Flow after changes in Working Capital

-29.05

-33.24

Cash Flow from Operating Activities

-29.46

-30.60

Cash Flow from Investing Activities

-280.63

3.63

Cash Flow from Financing Activities

478.47

30.82

Net Cash Inflow / Outflow

168.38

3.86

Opening Cash & Cash Equivalents

19.93

16.08

Cash & Cash Equivalent on Amalgamation / Take over / Merger

Cash & Cash Equivalent of Subsidiaries under liquidations

Translation adjustment on reserves / op cash balalces frgn subsidiaries

Effect of Foreign Exchange Fluctuations

Closing Cash & Cash Equivalent

188.32

19.93